These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 23741527

  • 1. Identification of a human protein-derived HIV-1 fusion inhibitor targeting the gp41 fusion core structure.
    Chao L, Lu L, Yang H, Zhu Y, Li Y, Wang Q, Yu X, Jiang S, Chen YH.
    PLoS One; 2013; 8(5):e66156. PubMed ID: 23741527
    [Abstract] [Full Text] [Related]

  • 2. The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors.
    Zhu Y, Ding X, Yu D, Chong H, He Y.
    J Virol; 2019 Dec 12; 94(1):. PubMed ID: 31619552
    [Abstract] [Full Text] [Related]

  • 3. HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain.
    Lu L, Tong P, Yu X, Pan C, Zou P, Chen YH, Jiang S.
    Biochim Biophys Acta; 2012 Dec 12; 1818(12):2950-7. PubMed ID: 22867851
    [Abstract] [Full Text] [Related]

  • 4. Identification of a critical motif for the human immunodeficiency virus type 1 (HIV-1) gp41 core structure: implications for designing novel anti-HIV fusion inhibitors.
    He Y, Cheng J, Li J, Qi Z, Lu H, Dong M, Jiang S, Dai Q.
    J Virol; 2008 Jul 12; 82(13):6349-58. PubMed ID: 18417584
    [Abstract] [Full Text] [Related]

  • 5. ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.
    Yu F, Lu L, Liu Q, Yu X, Wang L, He E, Zou P, Du L, Sanders RW, Liu S, Jiang S.
    Biochim Biophys Acta; 2014 May 12; 1838(5):1296-305. PubMed ID: 24388952
    [Abstract] [Full Text] [Related]

  • 6. Peptide and non-peptide HIV fusion inhibitors.
    Jiang S, Zhao Q, Debnath AK.
    Curr Pharm Des; 2002 May 12; 8(8):563-80. PubMed ID: 11945159
    [Abstract] [Full Text] [Related]

  • 7. Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120.
    Liu S, Lu H, Niu J, Xu Y, Wu S, Jiang S.
    J Biol Chem; 2005 Mar 25; 280(12):11259-73. PubMed ID: 15640162
    [Abstract] [Full Text] [Related]

  • 8. Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design.
    Cai L, Gochin M, Liu K.
    Curr Top Med Chem; 2011 Dec 25; 11(24):2959-84. PubMed ID: 22044229
    [Abstract] [Full Text] [Related]

  • 9. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
    Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R.
    J Mol Biol; 2004 Jun 25; 340(1):9-14. PubMed ID: 15184018
    [Abstract] [Full Text] [Related]

  • 10. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.
    Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.
    J Virol; 2017 Jan 01; 91(1):. PubMed ID: 27795416
    [Abstract] [Full Text] [Related]

  • 11. Identification of critical antibody-binding sites in the HIV-1 gp41 six-helix bundle core as potential targets for HIV-1 fusion inhibitors.
    Li J, Chen X, Huang J, Jiang S, Chen YH.
    Immunobiology; 2009 Jan 01; 214(1):51-60. PubMed ID: 19159827
    [Abstract] [Full Text] [Related]

  • 12. A novel bispecific peptide HIV-1 fusion inhibitor targeting the N-terminal heptad repeat and fusion peptide domains in gp41.
    Jiang X, Jia Q, Lu L, Yu F, Zheng J, Shi W, Cai L, Jiang S, Liu K.
    Amino Acids; 2016 Dec 01; 48(12):2867-2873. PubMed ID: 27631437
    [Abstract] [Full Text] [Related]

  • 13. Multimerized CHR-derived peptides as HIV-1 fusion inhibitors.
    Nomura W, Hashimoto C, Suzuki T, Ohashi N, Fujino M, Murakami T, Yamamoto N, Tamamura H.
    Bioorg Med Chem; 2013 Aug 01; 21(15):4452-8. PubMed ID: 23800723
    [Abstract] [Full Text] [Related]

  • 14. Covalent fusion inhibitors targeting HIV-1 gp41 deep pocket.
    Bai Y, Xue H, Wang K, Cai L, Qiu J, Bi S, Lai L, Cheng M, Liu S, Liu K.
    Amino Acids; 2013 Feb 01; 44(2):701-13. PubMed ID: 22961335
    [Abstract] [Full Text] [Related]

  • 15. Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action.
    Wexler-Cohen Y, Shai Y.
    PLoS Pathog; 2009 Jul 01; 5(7):e1000509. PubMed ID: 19593361
    [Abstract] [Full Text] [Related]

  • 16. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
    Korazim O, Sackett K, Shai Y.
    J Mol Biol; 2006 Dec 15; 364(5):1103-17. PubMed ID: 17045292
    [Abstract] [Full Text] [Related]

  • 17. Discovery of critical residues for viral entry and inhibition through structural Insight of HIV-1 fusion inhibitor CP621-652.
    Chong H, Yao X, Qiu Z, Qin B, Han R, Waltersperger S, Wang M, Cui S, He Y.
    J Biol Chem; 2012 Jun 08; 287(24):20281-9. PubMed ID: 22511760
    [Abstract] [Full Text] [Related]

  • 18. HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides.
    Liu S, Jing W, Cheung B, Lu H, Sun J, Yan X, Niu J, Farmar J, Wu S, Jiang S.
    J Biol Chem; 2007 Mar 30; 282(13):9612-9620. PubMed ID: 17276993
    [Abstract] [Full Text] [Related]

  • 19. Hydrophobic mutations in buried polar residues enhance HIV-1 gp41 N-terminal heptad repeat-C-terminal heptad repeat interactions and C-peptides' anti-HIV activity.
    Zheng B, Wang K, Lu L, Yu F, Cheng M, Jiang S, Liu K, Cai L.
    AIDS; 2014 Jun 01; 28(9):1251-60. PubMed ID: 24625369
    [Abstract] [Full Text] [Related]

  • 20. The potent human immunodeficiency virus type 1 (HIV-1) entry inhibitor HR212 blocks formation of the envelope glycoprotein gp41 six-helix bundle.
    Ouyang W, An T, Guo D, Wu S, Tien P.
    AIDS Res Hum Retroviruses; 2013 Mar 01; 29(3):613-20. PubMed ID: 23308369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.